What is being tested for CRPS right now?
Researchers are testing drugs, implanted devices, procedures and behavioral programs for complex regional pain syndrome (CRPS). ClinicalTrials.gov, the federal study registry, lists each registered study with its status, sponsor and sites. The figures on this page are pulled from the registry weekly and show how many CRPS studies are open, including those with a California site.

How many CRPS studies are registered, and how many are open right now?
The four figures below are counted from ClinicalTrials.gov on the retrieval date shown under them. The first counts every CRPS study ever registered, including studies that finished or stopped years ago. The second counts studies open to enrollment. The third narrows the open studies to those naming a California site, and the fourth counts studies the registry marks as completed.
- 244CRPS studies registered worldwideClinicalTrials.gov, November 20, 2026
- 43studies open to enrollment nowClinicalTrials.gov, November 20, 2026
- 8open studies with a California siteClinicalTrials.gov, November 20, 2026
- 124studies completedClinicalTrials.gov, November 20, 2026
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved . Search: condition matches "complex regional pain syndrome" OR "reflex sympathetic dystrophy" OR causalgia.
Which CRPS studies are open at California sites?
The table lists each open CRPS study that names a California site whose own status is recruiting, not yet recruiting, or not stated. The "what is being tested" column shows up to three of the treatments a study lists and leaves out placebo and sham arms. A study with no listed treatment appears as observational. The trial finder adds studies outside California.
| Study | What is being tested | Phase | California sites | Status |
|---|---|---|---|---|
| Empowered Relief for CaregiversNCT07636980 · Stanford University | Empowered Relief for Caregivers (ER-CY) | No phase (device or behavioral) | Palo Alto | Recruiting |
| Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)NCT07210515 · Ambros Therapeutics, Inc. | Neridronate | Phase 3 | La Jolla, Napa, Pasadena, Santa Monica, Tustin | Recruiting |
| Closed-Loop Deep Brain Stimulation for Refractory Chronic PainNCT04144972 · University of California, San Francisco | Medtronic Summit RC+S or Percept RC | No phase (device or behavioral) | San Francisco | Recruiting |
| TMS for Complex Regional Pain SyndromeNCT03137472 · Stanford University | Transcranial Magnetic Stimulation (TMS) | No phase (device or behavioral) | Redwood City | Recruiting |
| Observational Study of Ketamine Infusions for the Treatment of Chronic PainNCT05477004 · Theresa Lii | Ketamine | Not stated | Stanford | Enrolling by invitation |
| Closed Loop Spinal Cord Stimulation for Complex Regional Pain SyndromeNCT06421350 · Scripps Health | Spinal Cord Stimulation Device | No phase (device or behavioral) | La Jolla | Recruiting |
| Low-Dose Naltrexone for the Treatment of Complex Regional Pain SyndromeNCT02502162 · Stanford University | LDN | No phase (device or behavioral) | Palo Alto | Recruiting |
| The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain SyndromeNCT06393101 · University of California, San Diego | BRC-002 | Phase 1 | La Jolla, San Diego | Recruiting |
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved . Listing a study here is not a recommendation. A study's status can change after the retrieval date; confirm on ClinicalTrials.gov.
What kinds of treatment do CRPS studies test?
CRPS studies on ClinicalTrials.gov test drugs, devices, procedures and behavioral programs, and some only observe patients. In the registry data retrieved on November 20, 2026, drugs and devices were the two treatment types listed most often across all registered CRPS studies. Devices include spinal cord and dorsal root ganglion stimulators.
New trials matter because the existing evidence is thin. A 2023 Cochrane overview of treatments for CRPS in adults "found no high-certainty evidence for any comparison" (Ferraro 2023). The 2022 practical guidelines in Pain Medicine state that few drug trials in CRPS patients meet the criteria for level 1 or level 2 evidence.
What do the study statuses on ClinicalTrials.gov mean?
A study status is the sponsor's report of where recruitment stands. The meanings below follow the ClinicalTrials.gov glossary.
| Status | What ClinicalTrials.gov says the status means | Counted as open here |
|---|---|---|
| Not yet recruiting | The study has not started recruiting participants | Yes |
| Recruiting | The study is currently recruiting participants | Yes |
| Enrolling by invitation | The study selects participants from a group the researchers decided on in advance | Yes |
| Active, not recruiting | The study is ongoing, and no new participants are being enrolled | No |
| Completed | The study ended normally | No |
| Terminated or withdrawn | The study stopped early, after or before enrolling its first participant | No |
| Unknown | A study past its completion date whose status was not verified within the past two years | No |
What do the phases of a CRPS clinical trial mean?
A phase describes the stage of a trial of a drug or biological product, under definitions developed by the Food and Drug Administration. The ClinicalTrials.gov glossary describes Phase 1 trials as focused on safety, Phase 2 as gathering preliminary data on whether a drug works, and Phase 3 as gathering more information on safety and effectiveness, typically with more participants. Phase 4 trials take place after approval.
Many CRPS studies have no phase. The registry uses "Not Applicable" for "trials of devices or behavioral interventions," and the California table labels those studies "No phase (device or behavioral)."
What is ClinicalTrials.gov, and who enters the information?
ClinicalTrials.gov is a public registry of clinical studies run by the National Library of Medicine at the National Institutes of Health. Its terms state that the data "are provided to the National Library of Medicine by organizations and institutions that sponsor and implement the studies." The registry is updated daily.
Library staff perform a limited review of each record for apparent errors, deficiencies or inconsistencies. The glossary states that staff "do not verify the scientific validity or relevance of the submitted information." A record is the sponsor's description of a study, not a government review of it.
How was the CRPS trial list built?
A script on this site queries the public ClinicalTrials.gov interface for studies whose condition matches "complex regional pain syndrome," "reflex sympathetic dystrophy" or causalgia. The script keeps each study's identifier, title, status, dates, phase, sponsor, treatments, age limits and sites. A California site is one whose country is the United States and whose state is California.
The script runs weekly and keeps the last good file if the registry returns fewer than 100 studies. The full list is published at /data/trials.json.
What are the limits of the ClinicalTrials.gov data on CRPS?
The registry data has four limits that affect the CRPS list. A status can be out of date, which is why the registry keeps an "Unknown" category. Some listed studies enroll people with several chronic pain conditions, with CRPS as one. A study registered under another condition name does not appear. A registered study is a plan or a work in progress, not a result.
The registry's terms ask anyone who republishes its data to show the date the data was processed and to state any changes. This page shows the retrieval date, keeps only the fields named above, and rewrites status and phase codes into plain labels.
Does a listing mean a CRPS study is safe or right for me?
No. A listing means only that a sponsor registered the study. The ClinicalTrials.gov terms state that the government makes no warranties about the data, and this site does not recommend any study. Each record has eligibility criteria, which the glossary defines as the requirements a person must meet to take part.
Joining a study begins with informed consent, the process of learning and discussing the risks and potential benefits before deciding. A treating doctor can say how a study fits with current care.
How can a lawyer use the trial registry in a CRPS case?
A lawyer can use a ClinicalTrials.gov record to establish basic facts about a treatment under study: the sponsor, the phase, the start date, the sites and whether the study is still recruiting. A record can show that a treatment a client received, or was offered, was part of a registered study. The record does not show that a treatment works or that a person needs it. Those questions belong to the treating physicians and the medical witnesses in the case.
Common questions
Sources
Every source below was opened and read for this page. The date is when it was last checked.
- ClinicalTrials.gov study registry and APIDataset · U.S. National Library of Medicine · checked
- ClinicalTrials.gov Terms and ConditionsGovernment agency · U.S. National Library of Medicine · checked
- ClinicalTrials.gov Glossary Terms (recruitment status, phase, study type, quality control review)Government agency · U.S. National Library of Medicine · checked
- Interventions for treating pain and disability in adults with complex regional pain syndrome: an overview of systematic reviewsStudy · Cochrane Database of Systematic Reviews (Ferraro et al.), 2023 · checked
- Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th EditionClinical guideline · Pain Medicine (Harden et al.), 2022 · checked
- Complex Regional Pain SyndromeGovernment agency · National Institute of Neurological Disorders and Stroke · checked

Research and data
CRPS treatment
Prognosis: does CRPS go away?
CRPS clinical trial finder